A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 38/17 (2006.01) A61K 9/00 (2006.01) A61K 9/16 (2006.01) A61K 9/72 (2006.01)
Patent
CA 2195639
A drug delivery composition for nasal administration is provided which comprises the antiviral agent ICAM-1 and a bioadhesive material. The bioadhesive material may be a chitosan solution, a liquid formulation comprising a polymeric material or a plurality of bioadhesive microspheres. The polymeric material is preferably gellan gum or alginate. The microspheres may comprise starch, chitosan, hyaluronic acid, or gelatin.
Composition d'apport de médicament destinée à l'administration par voie nasale comprenant l'agent antiviral ICAM-1 et une matière bioadhésive. La matière bioadhésive peut être une solution de chitosane, une formulation liquide comprenant une matière polymère ou une pluralité de microsphères bioadhésives. La matière polymère est de préférence de la gomme de gellane ou de l'alginate. Les microsphères peuvent être formées avec l'amidon, du chitosane, de l'acide hyaluronique ou de la gélatine.
Illum Lisbeth
Watts Peter
Danbiosyst Uk Limited
Russell Reyneke
West Pharmaceutical Services Drug Delivery & Clinical Research C
LandOfFree
Drug delivery composition for the nasal administration of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Drug delivery composition for the nasal administration of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Drug delivery composition for the nasal administration of... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1415333